Activating Compound | Comment | Organism | Structure |
---|---|---|---|
bromocriptine | significantly upregulates expression and activity (911% of untreated control) of NQO1, attenuates increase in protein-bound quinone in H2O2-treated PC12 cells, and protects PC12 cells against oxidative damage. Bromocriptine increases the expression and nuclear translocation of a basic leucine zipper transcription factor Nrf2, involved in the regulation of the enzyme | Rattus norvegicus |
Application | Comment | Organism |
---|---|---|
drug development | cytoprotective effect of bromocriptine involving PI3K- and Nrf2-mediated upregulation of the antioxidant enzyme NQO1, which may be a therapeutic strategy to protect cells from oxidative damage in Parkinsons disease | Rattus norvegicus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
dicoumarol | in the presence of 0.050 mM of dicoumarol, the protective effect of bromocriptine against H2O2 is completely abolished | Rattus norvegicus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
PC-12 cell | - |
Rattus norvegicus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
NAD(P)H + H+ + oxidized 2,6-dichlorophenolindophenol | - |
Rattus norvegicus | NAD(P)+ + reduced 2,6-dichlorophenolindophenol | - |
? |
Synonyms | Comment | Organism |
---|---|---|
EC 1.6.99.2 | formerly | Rattus norvegicus |
NAD(P)H quinone oxidoreductase1 | - |
Rattus norvegicus |
NQO1 | - |
Rattus norvegicus |